Rani Therapeutics Holdings, Inc. (RANI) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 1.71M | 1.46M | 0 | 0 | 172K | 1.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96M |
| Revenue Growth % | 893.02% | 42.12% | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | - | - |
| Cost of Goods Sold | 161K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 248K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 9.43% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.55M | 1.46M | 0 | 0 | 172K | 1.03M | 0 | 0 | -248K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96M |
| Gross Margin % | 90.57% | 100% | - | - | 100% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% |
| Gross Profit Growth % | 799.42% | 42.12% | - | - | 169.35% | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | - | - |
| Operating Expenses | 9.89M | 10M | 7.26M | 10.51M | 12.19M | 15.99M | 11.8M | 12.52M | 13.79M | 13.43M | 17.86M | 18.29M | 16.52M | 17.48M | 16.34M | 15.85M | 13.78M | 13.36M | 27.78M | 7.22M |
| OpEx % of Revenue | 578.81% | 684.19% | - | - | 7084.3% | 1555.06% | - | - | - | - | - | - | - | - | - | - | - | - | - | 368.13% |
| Selling, General & Admin | 4.89M | 5.09M | 4.04M | 5M | 5.62M | 5.46M | 5.63M | 6.41M | 6.2M | 5.83M | 6.63M | 7.21M | 6.8M | 7.1M | 7.24M | 6.32M | 6.19M | 5.95M | 15.82M | 3.46M |
| SG&A % of Revenue | 286.07% | 348.19% | - | - | 3264.53% | 531.32% | - | - | - | - | - | - | - | - | - | - | - | - | - | 176.44% |
| Research & Development | 5.16M | 4.91M | 3.22M | 5.5M | 6.57M | 6.81M | 6.17M | 6.12M | 7.59M | 7.61M | 11.22M | 11.09M | 9.71M | 10.39M | 9.1M | 9.53M | 7.59M | 7.42M | 11.96M | 3.76M |
| R&D % of Revenue | 302.17% | 336% | - | - | 3819.77% | 662.45% | - | - | - | - | - | - | - | - | - | - | - | - | - | 191.69% |
| Other Operating Expenses | -161K | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.34M | -8.54M | -7.26M | -10.51M | -12.01M | -14.96M | -11.8M | -12.52M | -14.03M | -13.43M | -17.86M | -18.29M | -16.52M | -17.48M | -16.34M | -15.85M | -13.78M | -13.36M | -27.78M | -5.26M |
| Operating Margin % | -488.23% | -584.19% | - | - | -6984.3% | -1455.06% | - | - | - | - | - | - | - | - | - | - | - | - | - | -268.13% |
| Operating Income Growth % | 30.58% | 42.94% | 38.49% | 16.12% | 14.4% | -11.34% | 33.92% | 31.54% | 15.03% | 23.16% | -9.26% | -15.44% | -19.85% | -30.83% | 41.18% | -201.39% | -165.1% | -170.27% | - | - |
| EBITDA | -8.18M | -8.35M | -7.03M | -10.27M | -11.76M | -14.69M | -11.54M | -12.27M | -13.79M | -13.21M | -17.64M | -18.11M | -16.33M | -17.31M | -16.2M | -15.72M | -13.67M | -13.25M | -27.66M | -5.13M |
| EBITDA Margin % | -478.81% | -571.46% | - | - | -6838.37% | -1429.18% | - | - | - | - | - | - | - | - | - | - | - | - | - | -261.6% |
| EBITDA Growth % | 30.47% | 43.17% | 39.05% | 16.33% | 14.68% | -11.24% | 34.57% | 32.23% | 15.57% | 23.69% | -8.86% | -15.14% | -19.45% | -30.64% | 41.43% | -206.53% | -170.03% | -175.91% | - | - |
| D&A (Non-Cash Add-back) | 161K | 186K | 223K | 240K | 251K | 266K | 259K | 255K | 248K | 227K | 218K | 189K | 188K | 174K | 141K | 122K | 111K | 113K | 120K | 128K |
| EBIT | -8.34M | -8.73M | -7.19M | -10.35M | -11.79M | -14.6M | -11.38M | -12.09M | -13.48M | -12.76M | -17.02M | -17.4M | -15.63M | -16.66M | -15.96M | -15.81M | -13.77M | -13.35M | -28.55M | -5.32M |
| Net Interest Income | 324K | 37K | -657K | -719K | -725K | -764K | -923K | -837K | -745K | -621K | -477K | -370K | -316K | 99K | 27K | 35K | 15K | 16K | -97K | -156K |
| Interest Income | 412K | 384K | 68K | 158K | 218K | 360K | 414K | 439K | 549K | 675K | 839K | 896K | 891K | 818K | 379K | 35K | 15K | 16K | 13K | 13K |
| Interest Expense | 88K | 347K | 725K | 877K | 943K | 1.12M | 1.34M | 1.28M | 1.29M | 1.3M | 1.32M | 1.27M | 1.21M | 719K | 352K | 0 | 0 | 0 | 110K | 169K |
| Other Income/Expense | 324K | -539K | -657K | -719K | -725K | -764K | -923K | -837K | -745K | -621K | -477K | -370K | -316K | 99K | 27K | 35K | 15K | 17K | -882K | -226K |
| Pretax Income | -8.02M | -9.07M | -7.91M | -11.22M | -12.74M | -15.72M | -12.72M | -13.36M | -14.78M | -14.05M | -18.33M | -18.66M | -16.83M | -17.38M | -16.32M | -15.81M | -13.77M | -13.35M | -28.66M | -5.48M |
| Pretax Margin % | -469.26% | -621.08% | - | - | -7405.81% | -1529.38% | - | - | - | - | - | - | - | - | - | - | - | - | - | -279.65% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41K | -107K | 154K | 63K | -40K | 37K | 1K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.24% | 0.66% | -0.97% | -0.46% | 0.3% | -0.13% | -0.02% |
| Net Income | -7.03M | -10.3M | -5.41M | -6.69M | -7.26M | -8.95M | -6.78M | -6.8M | -7.48M | -7.1M | -9.2M | -9.3M | -8.37M | -8.79M | -7.96M | -7.62M | -6.22M | -5.19M | -3.14M | -5.49M |
| Net Margin % | -411.77% | -705.34% | - | - | -4223.26% | -870.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | -279.7% |
| Net Income Growth % | 3.18% | -15.18% | 20.21% | 1.66% | 2.93% | -26.05% | 26.25% | 26.85% | 10.62% | 19.21% | -15.61% | -22.02% | -34.53% | -69.32% | -153.18% | -39% | -11.16% | 68.93% | - | - |
| Net Income (Continuing) | -8.02M | -9.07M | -7.91M | -11.22M | -12.74M | -15.72M | -12.72M | -13.36M | -14.78M | -14.05M | -18.33M | -18.66M | -16.83M | -17.34M | -16.21M | -15.97M | -13.83M | -13.3M | -28.7M | -5.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 7.14M | 8.5M | -4.11M | -3.58M | -2.29M | 1.5M | 2.65M | 2.71M | 7.14M | 12.58M | 17.27M | 24.07M | 30.87M | 37.15M | 44.41M | 50.84M | 57.26M | 74.16M | 80.34M | 0 |
| EPS (Diluted) | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 | -0.26 | -0.16 | 0.30 |
| EPS Growth % | 82.23% | 74.07% | 50% | 30.77% | 24.14% | 0% | 33.33% | 29.73% | 12.12% | 22.86% | -9.09% | -19.35% | -13.79% | -34.62% | -106.25% | -203.33% | 3.33% | 70.79% | - | - |
| EPS (Basic) | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | -0.27 | -0.36 | -0.37 | -0.33 | -0.35 | -0.33 | -0.31 | -0.29 | -0.26 | -0.16 | 0.30 |
| Diluted Shares Outstanding | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.34M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M |
| Basic Shares Outstanding | 180M | 147.09M | 36.54M | 36.54M | 33.44M | 32.66M | 28.84M | 26.32M | 26.03M | 25.87M | 25.55M | 25.34M | 25.24M | 24.91M | 24.47M | 24.37M | 21.41M | 19.44M | 19.44M | 18.81M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |